Innovita COVID-19 Antibody Kit Approved by US FDA

On November 23, 2020, the US Food and Drug Administration (FDA) has granted the Innovita antibody kit an Emergency Use Authorization (EUA). The Innovita 2019-nCoV Ab Test (Colloidal Gold) is deemed as an instrumental diagnostic technology against the public health emergency caused by the COVID-19 pandemic. Below is the FDA report citing the reliability of the Innovita rapid test kits.

  • Text Hover
  • View FDA Evaluation Report

As a globally renowned test, the Innovita antibody kit is capable of aiding our country’s COVID-19 detection and isolation efforts for positive cases. For accredited testing organizations and LGUs interested in purchasing our Innovita kit, please feel free to fill out the form below.